Trigeminal Nerve Stimulation: A Recently Approved Treatment Approach in Attention Deficit Hyperactivity Disorder
View/
Access
info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nd/3.0/us/Date
2021Metadata
Show full item recordCitation
Çöpür, M., & Çöpür, S. (2021). Trigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57(1), 1-3.Abstract
Attention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications include methylphenidate, atomoxetine, and amphetamines while trigeminal nerve stimulator (TNS) is the first medical device in ADHD with FDA approval. The aim of this article is to evaluate the latest studies in this field.
Source
Egyptian Journal of Neurology Psychiatry and NeurosurgeryVolume
57Issue
1Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
